Scarica l'app Stockscreener
72.51
0.33%
-0.24
Pre-mercato:
72.71
0.20
+0.28%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$72.75
Aprire:
$73.5
Volume 24 ore:
1.66M
Relative Volume:
1.05
Capitalizzazione di mercato:
$12.97B
Reddito:
$342.96M
Utile/perdita netta:
$-864.29M
Rapporto P/E:
-13.06
EPS:
-5.55
Flusso di cassa netto:
$-636.03M
1 W Prestazione:
+11.13%
1M Prestazione:
-1.81%
6M Prestazione:
-4.01%
1 anno Prestazione:
+151.68%
Intervallo 1D:
$71.50
$73.62
Intervallo di 1 settimana:
$63.73
$73.62
Portata 52W:
$21.92
$80.53
Insmed Inc Stock (INSM) Company Profile
Nome
Insmed Inc
Settore
Industria
Telefono
908-977-9900
Indirizzo
700 US HIGHWAY 202/206, BRIDGEWATER, NJ
Confronta INSM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
INSM
Insmed Inc
|
72.51 | 12.97B | 342.96M | -864.29M | -636.03M | -5.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.00 | 108.68B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
681.58 | 74.90B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
640.52 | 38.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
246.27 | 31.76B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.93 | 26.83B | 3.30B | -501.07M | 1.03B | -2.1146 |
Insmed Inc Stock (INSM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-23 | Iniziato | Truist | Buy |
| 2024-02-15 | Iniziato | Wolfe Research | Outperform |
| 2023-12-08 | Iniziato | Wells Fargo | Overweight |
| 2023-11-20 | Ripresa | JP Morgan | Overweight |
| 2023-07-26 | Iniziato | Guggenheim | Buy |
| 2022-12-09 | Iniziato | Mizuho | Buy |
| 2022-12-07 | Iniziato | Barclays | Overweight |
| 2022-11-18 | Iniziato | BofA Securities | Buy |
| 2022-04-27 | Iniziato | Goldman | Buy |
| 2021-12-06 | Iniziato | JP Morgan | Overweight |
| 2021-10-19 | Ripresa | Monness Crespi & Hardt | Buy |
| 2021-10-19 | Ripresa | Morgan Stanley | Overweight |
| 2021-10-08 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-04-26 | Ripresa | Credit Suisse | Outperform |
| 2020-12-17 | Iniziato | Berenberg | Buy |
| 2020-10-12 | Ripresa | Stifel | Buy |
| 2019-09-03 | Iniziato | Goldman | Buy |
| 2019-04-09 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-15 | Aggiornamento | JMP Securities | Mkt Perform → Mkt Outperform |
| 2019-01-17 | Aggiornamento | Goldman | Neutral → Buy |
| 2019-01-02 | Iniziato | Canaccord Genuity | Buy |
| 2018-08-06 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-07-23 | Iniziato | Goldman | Neutral |
| 2018-04-23 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-03-21 | Iniziato | Morgan Stanley | Overweight |
| 2018-01-18 | Iniziato | Credit Suisse | Neutral |
| 2017-09-05 | Reiterato | Evercore ISI | Outperform |
| 2017-08-17 | Iniziato | Evercore ISI | Outperform |
| 2017-07-11 | Iniziato | Robert W. Baird | Outperform |
| 2016-03-15 | Iniziato | Stifel | Buy |
| 2015-11-09 | Downgrade | UBS | Buy → Neutral |
| 2015-10-06 | Reiterato | H.C. Wainwright | Buy |
| 2015-06-09 | Iniziato | Citigroup | Neutral |
| 2014-03-26 | Reiterato | HC Wainwright | Buy |
Mostra tutto
Insmed Inc Borsa (INSM) Ultime notizie
The five-year returns have been solid for Insmed (NASDAQ:INSM) shareholders despite underlying losses increasing - Yahoo Finance UK
Insmed CEO William Lewis sells shares worth $2.71 million - MSN
Insmed Incorporated (NASDAQ:INSM) Short Interest Up 18.7% in December - MarketBeat
Is Insmed (NASDAQ:INSM) Using Debt Sensibly? - Simply Wall St
Insmed chief medical officer sells $95,108 in stock - MSN
Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts? - Yahoo Finance
Insmed (FRA:IM8N) Shares Outstanding (EOP) : 178.8 Mil (As of Sep. 2024) - GuruFocus.com
Insmed's chief people strategy officer sells $59,923 in stock - MSN
Goldman Sachs Sees High Merger Odds For This Large-Cap Biopharma In Trump 2.0 Era: Retail Has Been Alert - MSN
Insmed Incorporated (NASDAQ:INSM) Insider Sells $95,108.48 in Stock - MarketBeat
Insmed Incorporated (NASDAQ:INSM) CEO William Lewis Sells 31,805 Shares of Stock - MarketBeat
Insmed COO Roger Adsett sells $100,125 in stock - MSN
Hennion & Walsh Asset Management Inc. Sells 43,522 Shares of Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed chief medical officer sells $95,108 in stock By Investing.com - Investing.com Australia
Assenagon Asset Management S.A. Has $36.26 Million Position in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insider Sell: Roger Adsett Sells 1,457 Shares of Insmed Inc (INS - GuruFocus.com
Insider Sell: Schaeffer Orlov S Nicole Sells Shares of Insmed In - GuruFocus.com
Insmed's chief people strategy officer sells $59,923 in stock By Investing.com - Investing.com Australia
Insmed COO Roger Adsett sells $100,125 in stock By Investing.com - Investing.com South Africa
Insmed CEO William Lewis sells shares worth $2.71 million By Investing.com - Investing.com Canada
Why INSM Stock Is Advancing Today - MSN
Insmed’s gene therapy poised to challenge DMD landscape after IND clearance - Yahoo Finance
Evolving Landscape of Cardiology Segment: Key Market Insights of Latest Published Rare Cardiovascular Diseases Report — Giant-Cell Arteritis, Pulmonary Arterial Hypertension, and Restrictive Cardiomyopathy | DelveInsight - GlobeNewswire Inc.
Capital CS Group LLC Buys New Stake in Insmed Incorporated (NASDAQ:INSM) - MarketBeat
Insmed (NASDAQ:INSM) Stock Price Up 6%Should You Buy? - MarketBeat
How Is The Market Feeling About Insmed? - Benzinga
Insmed issues preliminary revenue results, guidance for Arikayce - MSN
Insmed COO Roger Adsett sells $368,472 in stock By Investing.com - Investing.com Nigeria
Insmed chief commercial officer sells shares worth $659,800 By Investing.com - Investing.com Australia
Insmed chief legal officer sells $242,815 in common stock By Investing.com - Investing.com Australia
Insmed’s chief medical officer sells $725,820 in stock By Investing.com - Investing.com Nigeria
Insmed's chief medical officer sells $725,820 in stock By Investing.com - Investing.com Australia
Insmed CFO Sara Bonstein sells $392,601 in stock By Investing.com - Investing.com Australia
Insmed Incorporated (NASDAQ:INSM) Stock Holdings Boosted by Harbor Capital Advisors Inc. - MarketBeat
Insmed's chief medical officer sells $725,820 in stock - Investing.com India
Insmed CFO Sara Bonstein sells $392,601 in stock - Investing.com India
Insmed Incorporated (NASDAQ:INSM) CFO Sells $67,925.52 in Stock - MarketBeat
Insmed CEO William Lewis sells $995,012 in stock By Investing.com - Investing.com South Africa
Insmed CEO William Lewis sells $995,012 in stock - Investing.com India
Insmed chief people strategy officer sells shares worth $312,259 By Investing.com - Investing.com Canada
Insmed Inc Azioni (INSM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Insmed Inc Azioni (INSM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Adsett Roger | Chief Operating Officer |
Jan 14 '25 |
Sale |
68.72 |
1,457 |
100,125 |
146,082 |
| Schaeffer Orlov S Nicole | Chief People Strategy Officer |
Jan 14 '25 |
Sale |
68.72 |
872 |
59,924 |
97,083 |
| Lewis William | Chair and CEO |
Jan 15 '25 |
Option Exercise |
22.76 |
18,750 |
426,750 |
411,339 |
| Lewis William | Chair and CEO |
Jan 15 '25 |
Option Exercise |
10.85 |
6,830 |
74,106 |
240,754 |
| Lewis William | Chair and CEO |
Jan 15 '25 |
Sale |
70.18 |
31,805 |
2,232,161 |
379,534 |
| Lewis William | Chair and CEO |
Jan 15 '25 |
Sale |
70.17 |
6,830 |
479,295 |
233,924 |
0.65%
4.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):